UnitedHealth Group reported outstanding Q4 and full-year 2019 results, exceeding earnings expectations with a 17% growth in adjusted EPS and strong revenue increases. Management expressed high confidence for 2020, highlighting robust growth in Medicare Advantage enrollments, successful cost management initiatives, and optimistic earnings guidance. The strong financial performance and positive outlook are likely to lead to a significant short-term rally in the stock price.

[2]